Background: The management of atrial isomerism across various countries may impact survival outcomes. Methods: This retrospective study involved patients diagnosed with atrial isomerism undergoing single ventricular palliation between 2000 and 2021. The objective was to evaluate survival outcomes within the right atrial isomerism (RAI) and left atrial isomerism (LAI) groups, as well as overall survival. Results: Of the 125 patients diagnosed with atrial isomerism, 105 (84%) had RAI, and 20 (16%) had LAI. The median age at presentation was 3 days (range: birth to 7.1 years), with median follow-up of 6.6 years (range: 0.59 months to 30.8 years). In the overall cohort, survival rates at one, five, and ten years were 85.6%, 72.3%, and 66.8%, respectively, with no statistically significant difference between RAI and LAI groups (log rank P value = .293). Specifically, survival rates in the RAI group at one, five, and ten years were 83.8%, 69.0%, and 62.6%, respectively, while in the LAI group, there were 95.0%, 89.7%, and 81.6%, respectively. Following the third-stage operation, overall survival rates at one and five years were 76.4% and 76.4%, respectively. Among patients in the RAI group, survival rates at one and five years post-third stage operation were 80.2% and 80.2%, respectively. Conclusions: Despite resource limitations, the survival outcomes of patients with atrial isomerism were found to be similar with those observed in high-income countries. Although an increased mortality rate was noted within the first year of life, focusing efforts on neonatal and infant care holds potential for improving overall outcomes.
BabanACantaruttiNAdorisioR, et al.Long-term survival and phenotypic spectrum in heterotaxy syndrome: a 25-year follow-up experience. Int J Cardiol. 2018;268:100-105. doi:https://doi.org/10.1016/j.ijcard.2018.02.050
2.
LinAEKrikovSRiehle-ColarussoT, et al.Laterality defects in the national birth defects prevention study (1998-2007): birth prevalence and descriptive epidemiology. Am J Med Genet A. 2014;164(10):2581-2591. doi:https://doi.org/10.1002/ajmg.a.36695
3.
KimSJKimWHLimHGLeeCHLeeJY. Improving results of the Fontan procedure in patients with heterotaxy syndrome. Ann Thorac Surg. 2006;82(4):1245-1251. doi:https://doi.org/10.1016/j.athoracsur.2006.04.082
4.
AnagnostopoulosPVPearlJMOctaveC, et al.Improved current era outcomes in patients with heterotaxy syndromes. Eur J Cardiothorac Surg. 2009;35(5):871-877; discussion 877-8. doi:https://doi.org/10.1016/j.ejcts.2008.12.018
5.
ChenWMaLCuiH, et al.Early- and middle-term surgical outcomes in patients with heterotaxy syndrome. Cardiology. 2016;133(3):141-146. doi:https://doi.org/10.1159/000440947
6.
Escobar-DiazMCFriedmanKSalemY, et al.Perinatal and infant outcomes of prenatal diagnosis of heterotaxy syndrome (asplenia and polysplenia). Am J Cardiol. 2014;114(4):612-617. doi:https://doi.org/10.1016/j.amjcard.2014.05.042
7.
EronenMPAittomakiKAKajantieEOSairanenHIPesonenEJ. The outcome of patients with right atrial isomerism is poor. Pediatr Cardiol. 2013;34(2):302-307. doi:https://doi.org/10.1007/s00246-012-0445-y
8.
BergCGeipelAKamilD, et al.The syndrome of right isomerism—prenatal diagnosis and outcome. Ultraschall Med. 2006;27(3):225-233. doi:https://doi.org/10.1055/s-2005-858639
9.
GilljamTMcCrindleBWSmallhornJFWilliamsWGFreedomRM. Outcomes of left atrial isomerism over a 28-year period at a single institution. J Am Coll Cardiol. 2000;36(3):908-916. doi:https://doi.org/10.1016/s0735-1097(00)00812-3
OtaNFujimotoYMurataM, et al.Improving outcomes of the surgical management of right atrial isomerism. Ann Thorac Surg. 2012;93(3):832-838; discussion 838-9. doi:https://doi.org/10.1016/j.athoracsur.2011.05.110
12.
GrahamGDearaniJANiazTCrowSCettaFStephensEH. Outcomes of biventricular and single ventricle heterotaxy patients: a single center five-decade experience. Ann Thorac Surg. 2023;115(5):1206-1211. doi:https://doi.org/10.1016/j.athoracsur.2022.05.045
13.
MakhijaZMarwahAMishraSKumarJGoelASharmaR. Biventricular repair in heterotaxy patients. World J Pediatr Congenit Heart Surg. 2015;6(2):195-202. doi:https://doi.org/10.1177/2150135114563772
14.
StephensEHGrahamGDearaniJANiazTCettaF. Fontan palliation in patients with heterotaxy syndrome: a five decade experience. World J Pediatr Congenit Heart Surg. 2022;13(4):436-442. doi:https://doi.org/10.1177/21501351221099944
15.
TanimotoKHoashiTShibagakiK, et al.Long-term outcomes of functional single ventricles associated with heterotaxy syndrome. Eur J Cardiothorac Surg. 2023;64(6). doi:https://doi.org/10.1093/ejcts/ezad311
16.
ZouMHCaoFMaL, et al.Outcomes of the surgical management of atrial isomerism and functional single ventricle: a single-centered cohort from China. Front Cardiovasc Med. 2021;8:664752. doi:https://doi.org/10.3389/fcvm.2021.664752
17.
ChenWLuYMaL, et al.Outcomes of treatment for right atrial isomerism with functional single ventricle and extracardiac total anomalous pulmonary venous connection beyond neonatal period: delayed surgical treatment, improving outcomes. Front Cardiovasc Med. 2022;9:914609. doi:https://doi.org/10.3389/fcvm.2022.914609
18.
NakayamaYHiramatsuTIwataY, et al.Surgical results for functional univentricular heart with total anomalous pulmonary venous connection over a 25-year experience. Ann Thorac Surg. 2012;93(2):606-613. doi:https://doi.org/10.1016/j.athoracsur.2011.09.038
19.
KhanMSBryantR3rdKimSH, et al.Contemporary outcomes of surgical repair of total anomalous pulmonary venous connection in patients with heterotaxy syndrome. Ann Thorac Surg. 2015;99(6):2134-2139; discussion 2139-40. doi:https://doi.org/10.1016/j.athoracsur.2015.02.035
20.
AlsoufiBMcCrackenCSchlosserB, et al.Outcomes of multistage palliation of infants with functional single ventricle and heterotaxy syndrome. J Thorac Cardiovasc Surg. 2016;151(5):1369-1377.e2. doi:https://doi.org/10.1016/j.jtcvs.2016.01.054
21.
MaratheSPCaoJYCelermajerD, et al.Outcomes of the Fontan operation for patients with heterotaxy: a meta-analysis of 848 patients. Ann Thorac Surg. 2020;110(1):307-315. doi:https://doi.org/10.1016/j.athoracsur.2019.11.027
22.
MaratheSPZanninoDCaoJY, et al.Heterotaxy is not a risk factor for adverse long-term outcomes after Fontan completion. Ann Thorac Surg. 2020;110(2):646-653. doi:https://doi.org/10.1016/j.athoracsur.2019.11.015
23.
LoombaRSNijhawanKAndersonR. Impact of era, type of isomerism, and ventricular morphology on survival in heterotaxy: implications for therapeutic management. World J Pediatr Congenit Heart Surg. 2016;7(1):54-62. doi:https://doi.org/10.1177/2150135115601831
